NIH-funded research NIH-funded research

Post-COVID Neurocognitive Changes: What We Learn About Veterans

Official title: Characteristics and Determinants of Post-COVID Neurocognitive Dysfunction

Funded at VA North Texas Health Care System · NIH-11620617 · Data updated 2026-11-12

This study will follow Veterans who had COVID-19 to understand how brain function and thinking skills may be affected over time.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA North Texas Health Care System
NIH-funded
Lab location1 site (Dallas, United States)
Project startJuly 1, 2024
Project endJune 30, 2028
Funding year2026
NIH project number5I01CX002739-03
Project IDNIH-11620617 on NIH RePORTER

Who could benefit from this research

Could help

Veterans who survived acute COVID-19 and are part of the EPIC3 cohort or eligible to join this cohort.

Less likely to help

Individuals not affected by COVID-19-related cognitive issues or not enrolled in the cohort may not directly benefit.

What this research studies

This project will use data and biospecimens from the VA EPIC3 COVID-19 cohort to map long-term brain-related symptoms after infection. Researchers will examine possible links between biomarkers, imaging results, and neurocognitive changes to identify patterns. The goal is to better predict who might develop lasting cognitive effects and to explore potential preventive or treatment approaches. Participants would contribute clinical data and biospecimens as part of the ongoing cohort study.

Why it matters

Potential benefit: If successful, findings could help clinicians recognize and manage post-COVID cognitive problems in veterans sooner.

How similar studies have gone: Existing data suggest neurocognitive changes after COVID-19, but comprehensive biomarker-imaging links in a well-characterized veteran cohort are still being developed.

Where this research is happening

  • VA North Texas Health Care System
    Dallas, United States
    Active

Researchers

  • Principal investigator: Bedimo, Roger — VA North Texas Health Care System
  • Study coordinator: Bedimo, Roger

Related research

Other NIH-funded projects on the same topics.

  • Personalized CKD-MBD care using systems biology and AI

    A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11644324

  • Targeting the DC-HIL pathway to treat melanoma

    A new approach aims to block the DC-HIL pathway to help people with melanoma by affecting tumor blood vessels and immune response.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11212795

  • Myeloid immune cells that may drive autoimmune damage in the brain and spinal cord

    This project looks at a specific group of immune cells to understand how they might cause or worsen autoimmune attacks in the brain and spinal cord for people with conditions like multiple sclerosis.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11212736

  • Blood pressure–guided fluid removal during hemodialysis

    This project uses blood pressure patterns recorded during dialysis to guide how much fluid is removed for people on hemodialysis.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11132726

  • Using blood pressure patterns to improve fluid management in dialysis patients

    This study is looking at how keeping an eye on blood pressure during dialysis can help doctors safely remove extra fluid from patients with severe kidney disease, especially veterans, to make their treatment safer and improve their health.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11056677

  • Investigating how MIF-CD74 signaling affects immune responses in pancreatic cancer.

    This study is looking at how certain immune cells in pancreatic cancer might be holding back the body's ability to fight the disease, and it hopes to find new ways to boost the immune response to help patients with this tough cancer.

    NIH research VA North Texas Health Care System · Dallas, United States · NIH-11052061

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.